Akèy › Maladi Alzheimer › Georgia › Atlanta
Etid klinik pou Maladi Alzheimer nan Atlanta, GA
16 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote Atlanta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Ap rekriteFaz 3
- Local Institution - 2611, Atlanta
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Ap rekriteFaz 4
- Accel Research - NeuroStudies, Decatur · 6 mi lwen
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
Ap rekriteFaz 1Volontè an sante akeyi
- Local Institution - 0004, Decatur · 6 mi lwen
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Ap rekriteFaz 3
- Agile Clinical Research Trials, LLC, Atlanta
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Ap rekriteFaz 3
- Grady Memorial Hospital, Atlanta
- Accel Research Sites-NeuroStudies, Decatur · 6 mi lwen
- CenExel iResearch, LLC, Decatur · 6 mi lwen
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Ap rekriteFaz 3
- Agile Clinical Research Trials, LLC, Atlanta
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Ap rekriteFaz 2
- CenExel iResearch, LLC, Decatur · 6 mi lwen
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Ap rekriteFaz 2
- CenExel iResearch, LLC ( Site 1015), Decatur · 6 mi lwen
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Ap rekriteFaz 1
- CenExel iResearch, LLC (CenExel iRA), Decatur · 6 mi lwen
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Ap rekriteFaz 3
- Emory University School of Medicine, Atlanta
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Ap rekriteFaz 2/3Volontè an sante akeyi
- Emory University, Atlanta
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Ap rekriteFaz 2/3Volontè an sante akeyi
- Emory University, Atlanta
Moving Yourself in Space and Time: MYSTIC
Ap rekriteVolontè an sante akeyi
- Emory University, Executive Park, Wesley Woods, Atlanta
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Ap rekriteFaz 1Volontè an sante akeyi
- Atlanta Center of Medical Research, Atlanta
- CenExel iResearch, LLC (CenExel iRA), Decatur · 6 mi lwen
Inspiring Seniors Towards Exercise Promotion to Protect Cognition
Ap rekriteVolontè an sante akeyi
- Emory University, Atlanta
Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
Ap rekrite
- Emory Rehabilitation Hospital, Atlanta
Etid Maladi Alzheimer nan lòt vil
- Boston, MA26 etid
- Orlando, FL25 etid
- St. Louis, MO22 etid
- New York City, NY21 etid
- Miami, FL20 etid
- Tampa, FL17 etid
- Philadelphia, PA15 etid
- The Villages, FL15 etid
- Phoenix, AZ15 etid
- Indianapolis, IN14 etid
- Los Angeles, CA14 etid
- West Palm Beach, FL13 etid
Lòt etid nan Atlanta
- Kansè (tout kalite)49 etid
- Kansè Poumon ki pa ti selil47 etid
- Myelom Miltip42 etid
- Kansè nan tete41 etid
- Kansè pwostat33 etid
- Leksemi mieloïd egi31 etid
- Kansè ovè29 etid
- Kansè kolorektal29 etid
- Kansè poumon29 etid
- Kansè Metastatik28 etid
- Twoub depresif majè25 etid
- Ensifizyans kadyak25 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.